Durrant, David E. et al
"Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity." Molecular Pharmacology
88.3
(2015):
512-523.
Web. 28 Mar. 2024.